tecovirimat will improve the level or influence of diazepam by affecting hepatic enzyme CYP2C19 metabolism. Use Warning/Watch. Tecovirimat is a weak inhibitor of CYP2C8 and CYP2C19. Monitor for adverse outcomes if coadministered with delicate substrates of such enzymes.enasidenib will enhance the level or outcome of diazepam by influencing hepatic … Read More